Kwan‐Young Jung

1.3k total citations
52 papers, 975 citations indexed

About

Kwan‐Young Jung is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Kwan‐Young Jung has authored 52 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 18 papers in Physiology and 13 papers in Organic Chemistry. Recurrent topics in Kwan‐Young Jung's work include Adenosine and Purinergic Signaling (18 papers), Pharmacological Receptor Mechanisms and Effects (11 papers) and Ubiquitin and proteasome pathways (6 papers). Kwan‐Young Jung is often cited by papers focused on Adenosine and Purinergic Signaling (18 papers), Pharmacological Receptor Mechanisms and Effects (11 papers) and Ubiquitin and proteasome pathways (6 papers). Kwan‐Young Jung collaborates with scholars based in South Korea, United States and Poland. Kwan‐Young Jung's co-authors include Yong‐Chul Kim, Kenneth A. Jacobson, Jeremy L. Yap, Steven Fletcher, Zhan‐Guo Gao, Alexander D. MacKerell, Kenno Vanommeslaeghe, Paul T. Wilder, Soo‐Kyung Kim and Ariel S. Gross and has published in prestigious journals such as Nature Communications, Biochemistry and Scientific Reports.

In The Last Decade

Kwan‐Young Jung

50 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kwan‐Young Jung South Korea 18 562 364 213 112 62 52 975
Andreas Brunschweiger Germany 21 1.1k 2.0× 576 1.6× 223 1.0× 59 0.5× 44 0.7× 49 1.5k
Todd Bosanac United States 18 349 0.6× 313 0.9× 74 0.3× 88 0.8× 102 1.6× 26 949
Massimo Castorina Italy 18 470 0.8× 400 1.1× 49 0.2× 181 1.6× 69 1.1× 22 935
Paul Beswick United Kingdom 20 443 0.8× 471 1.3× 74 0.3× 83 0.7× 89 1.4× 38 1.0k
Hyuk Woo Lee South Korea 21 737 1.3× 317 0.9× 370 1.7× 187 1.7× 41 0.7× 43 1.2k
Jeffrey M. Axten United States 16 933 1.7× 322 0.9× 36 0.2× 73 0.7× 149 2.4× 29 1.9k
Erica W. van Tilburg Netherlands 14 494 0.9× 119 0.3× 257 1.2× 75 0.7× 60 1.0× 18 773
Edward F. Greenberg United States 12 1.1k 1.9× 172 0.5× 61 0.3× 409 3.7× 61 1.0× 19 1.2k
Alexander Y. Kots United States 18 404 0.7× 122 0.3× 105 0.5× 110 1.0× 46 0.7× 35 941
Haixia Zou China 9 382 0.7× 99 0.3× 109 0.5× 43 0.4× 26 0.4× 11 782

Countries citing papers authored by Kwan‐Young Jung

Since Specialization
Citations

This map shows the geographic impact of Kwan‐Young Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kwan‐Young Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kwan‐Young Jung more than expected).

Fields of papers citing papers by Kwan‐Young Jung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kwan‐Young Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kwan‐Young Jung. The network helps show where Kwan‐Young Jung may publish in the future.

Co-authorship network of co-authors of Kwan‐Young Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Kwan‐Young Jung. A scholar is included among the top collaborators of Kwan‐Young Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kwan‐Young Jung. Kwan‐Young Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huber, Andrew D., Wenwei Lin, Kwan‐Young Jung, et al.. (2025). PROTAC repurposing uncovers a noncanonical binding surface that mediates chemical degradation of nuclear receptors. Nature Communications. 16(1). 9805–9805.
2.
Wang, Jingheng, Stanley Nithianantham, Sergio C. Chai, et al.. (2025). Decoding the selective chemical modulation of CYP3A4. Nature Communications. 16(1). 3423–3423. 1 indexed citations
3.
Jung, Kwan‐Young, Yeo Ok Kim, Hyung Gon Lee, et al.. (2022). Development of Dibenzothiazepine Derivatives as Multifunctional Compounds for Neuropathic Pain. Pharmaceuticals. 15(4). 407–407. 1 indexed citations
4.
Jung, Kwan‐Young, Qasim Shah, Julie Pelletier, et al.. (2022). Synthesis and pharmacological characterization of multiply substituted 2H-chromene derivatives as P2Y6 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 75. 128981–128981. 12 indexed citations
5.
Salmaso, Veronica, Kwan‐Young Jung, Qasim Shah, et al.. (2022). Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2Y14R Antagonist. Journal of Medicinal Chemistry. 65(4). 3434–3459. 14 indexed citations
6.
Jung, Kwan‐Young, et al.. (2021). Structure activity relationship of 3-nitro-2-(trifluoromethyl)-2H-chromene derivatives as P2Y6 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 41. 128008–128008. 13 indexed citations
7.
Kim, Ye-Hyun, Chong Hak Chae, Jiyeon Ahn, et al.. (2021). Discovery and Characterization of a Novel MASTL Inhibitor MKI-2 Targeting MASTL-PP2A in Breast Cancer Cells and Oocytes. Pharmaceuticals. 14(7). 647–647. 8 indexed citations
8.
Jain, Shanu, Sai P. Pydi, Kwan‐Young Jung, et al.. (2021). Adipocyte P2Y14 receptors play a key role in regulating whole-body glucose and lipid homeostasis. JCI Insight. 6(10). 19 indexed citations
9.
Lee, Sang Chul, Tae Ho Hong, Kee‐Hwan Kim, et al.. (2020). A Novel Way of Preventing Postoperative Pancreatic Fistula by Directly Injecting Profibrogenic Materials into the Pancreatic Parenchyma. International Journal of Molecular Sciences. 21(5). 1759–1759. 8 indexed citations
10.
Kim, Ah Young, Kwan‐Young Jung, Jiyeon Ahn, et al.. (2020). MKI-1, a Novel Small-Molecule Inhibitor of MASTL, Exerts Antitumor and Radiosensitizer Activities Through PP2A Activation in Breast Cancer. Frontiers in Oncology. 10. 571601–571601. 12 indexed citations
11.
You, Dong Do, Jin Sook Song, Kyu-Seok Hwang, et al.. (2019). Superior gallstone dissolubility and safety of tert-amyl ethyl ether over methyl-tertiary butyl ether. World Journal of Gastroenterology. 25(39). 5936–5952. 4 indexed citations
12.
Kim, Young Hun, Minsung Kim, Ji Eun Kim, et al.. (2018). A natural compound, aristoyagonine, is identified as a potent bromodomain inhibitor by mid-throughput screening. Biochemical and Biophysical Research Communications. 503(2). 882–887. 12 indexed citations
13.
Jung, Kwan‐Young, et al.. (2018). Deacetylation of Unactivated Amide Bonds in Heterocyclic Systems Using t ‐BuOK. ChemistrySelect. 3(5). 1527–1530. 6 indexed citations
14.
Jung, Kwan‐Young, Seung Kyu Kang, Haushabhau S. Pagire, et al.. (2017). Design, synthesis, and biological evaluation of aryl N-methoxyamide derivatives as GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 27(16). 3909–3914. 11 indexed citations
15.
Kim, Myeong-Ok, Jiyeon Ahn, Kwan‐Young Jung, et al.. (2017). Antihelminthic drug niclosamide inhibits CIP2A and reactivates tumor suppressor protein phosphatase 2A in non-small cell lung cancer cells. Biochemical Pharmacology. 144. 78–89. 32 indexed citations
16.
Kang, Seung Kyu, Kwan‐Young Jung, Ashok Kumar Jaladi, et al.. (2014). Synthesis and biological evaluation of thienopyrimidine derivatives as GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 24(17). 4281–4285. 10 indexed citations
17.
Jung, Kwan‐Young, et al.. (2013). Synthesis and structure–activity relationships of carboxylic acid derivatives of pyridoxal as P2X receptor antagonists. Bioorganic & Medicinal Chemistry. 21(9). 2643–2650. 12 indexed citations
18.
Jung, Kwan‐Young, et al.. (2013). Design and synthesis of potent and selective P2X3 receptor antagonists derived from PPADS as potential pain modulators. European Journal of Medicinal Chemistry. 70. 811–830. 15 indexed citations
19.
Jung, Kwan‐Young, Ramin Samadani, Jay Chauhan, et al.. (2013). Structural modifications of (Z)-3-(2-aminoethyl)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione that improve selectivity for inhibiting the proliferation of melanoma cells containing active ERK signaling. Organic & Biomolecular Chemistry. 11(22). 3706–3706. 28 indexed citations
20.
Yap, Jeremy L., Xiaobo Cao, Kenno Vanommeslaeghe, et al.. (2012). Relaxation of the rigid backbone of an oligoamide-foldamer-based α-helix mimetic: identification of potent Bcl-xL inhibitors. Organic & Biomolecular Chemistry. 10(15). 2928–2928. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Brunschweiger Breakdown of academic impact, for papers by Todd Bosanac Breakdown of academic impact, for papers by Massimo Castorina Breakdown of academic impact, for papers by Paul Beswick Breakdown of academic impact, for papers by Hyuk Woo Lee Breakdown of academic impact, for papers by Jeffrey M. Axten Breakdown of academic impact, for papers by Erica W. van Tilburg Breakdown of academic impact, for papers by Edward F. Greenberg Breakdown of academic impact, for papers by Alexander Y. Kots Breakdown of academic impact, for papers by Haixia Zou
Rankless by CCL
2026